ReviewJournal of neurology2014
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.
Review in Journal of neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 8 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
145 citing papers in PubMed, 8 syntheses or guidelines pooled it, 328 citations in OpenAlex.
- Mapping Neuro Behcet's Disease Across North Africa: a Systematic Review and Meta Analysis.Clinical reviews in allergy & immunology · 2026Pooled it
- Epidemiology and clinical features of Behçet's disease in the Middle East and North Africa:A systematic review and meta-analysis.Clinical rheumatology · 2026Pooled it
- Clinical and imaging features of parenchymal and non-parenchymal neuro-Behçet's disease: a systematic review of case reports and series.BMC neurology · 2025Pooled it
- The effectiveness of the anti-tumor necrosis factor therapy infliximab in neuro-Behçet's disease: a systematic review and meta-analysis.The Journal of international medical research · 2023Pooled it
- A Systematic Review of Neurocognitive Functioning in Behçet's Disease.Neuropsychology review · 2019Pooled it
- Clinical and imaging features of spinal cord type of neuro Behçet disease: A case report and systematic review.Medicine · 2017Pooled it
- Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis.Scientific reports · 2017Pooled it
- Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome.The Cochrane database of systematic reviews · 2014Pooled it
- Clinical characteristics of headache in the patients with Neuro-Behçet's disease.Acta neurologica Belgica · 2026Article
- Glymphatic dysfunction as a potential mechanistic link to cognitive ımpairment in Behçet's disease: a hypothesis.Rheumatology international · 2026Article
- Clinical Images: Tumor necrosis factor inhibitor-associated demyelination in a case of neuro-Behçet disease.ACR open rheumatology · 2026Article
- Comorbid Inflammatory Diseases in Behçet's Disease: A Multicenter Large Cohort Study.International journal of rheumatic diseases · 2026Observational
- Beyond Venous Inflammation: Vessel Wall Imaging of Intracranial Arteries in Neuro-Behçet's Syndrome.European journal of neurology · 2026Article
- Familial aggregation in Behçet's Disease: Sibling history as a risk factor for Neuro-Behçet.Irish journal of medical science · 2026Article
- Treat-to-target in Behçet syndrome.Nature reviews. Rheumatology · 2026Review
- Aging in Behçet's syndrome: an overlooked risk for late-life cognitive impairment.Aging clinical and experimental research · 2026Review
- Targeting the BlyS/APRIL axis in neuro-Behçet disease: a rationale for telitacicept as a steroid-sparing strategy.Annals of medicine and surgery (2012) · 2026Article
- Severe neuro-behçet's disease refractory: Radiologic improvement with tocilizumab.Radiology case reports · 2026Article
- Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma.Journal of neurology · 2026Article
- Neuro-behcet's syndrome: epidemiology, mechanisms, and emerging strategies in diagnosis and treatment.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Review
85 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 10 institutions in 7 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuro-Behçet's disease (NBD) is one of the more serious manifestations of Behçet's disease (BD), which is a relapsing inflammatory multisystem disease with an interesting epidemiology. Though NBD is relatively uncommon, being potentially treatable, neurologists need to consider it in the differential diagnosis of inflammatory, infective, or demyelinating CNS disorders. Evidence-based information on key issues of NBD diagnosis and management is scarce, and planning for such studies is challenging. We therefore initiated this project to develop expert consensus recommendations that might be helpful to neurologists and other clinicians, created through an extensive literature review and wide consultations with an international advisory panel, followed by a Delphi exercise. We agreed on consensus criteria for the diagnosis of NBD with two levels of certainty in addition to recommendations on when to consider NBD in a neurological patient, and on the use of various paraclinical tests. The management recommendations included treatment of the parenchymal NBD and cerebral venous thrombosis, the use of disease modifying therapies, prognostic factors, outcome measures, and headache in BD. Future studies are needed to validate the proposed criteria and provide evidence-based treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.